| http://dbpedia.org/ontology/abstract
|
Die BB Biotech AG ist eine Schweizer Biotechnologie-Investmentgesellschaft.
, BB Biotech è una delle più grandi società di investimento nel campo delle biotecnologie del mondo. La società è quotata sul listino di Borsa Italiana dove è presente nell'indice FTSE Italia STAR.
, BB Biotech (SIX : BIO) est une entreprise suisse qui faisait partie de l'indice TecDAX. BB Biotech est une société de portefeuille spécialisée dans la prise de participations dans des sociétés de biotechnologies.
, BB Biotech AG is a Swiss investment compan … BB Biotech AG is a Swiss investment company in the field of biotechnology. Since 1993 it is listed on the SIX Swiss Exchange, since 1997 on the German TecDAX and since 2000 on the Italian Borsa Italiana. The company invests mainly in the United States and Western Europe. BB Biotech is managed by Bellevue Asset Management, a division of Bellevue Group and accounts for approximately 40% of the Group's Assets Under Management.0% of the Group's Assets Under Management.
|
| http://dbpedia.org/ontology/assets
|
4.357E9
|
| http://dbpedia.org/ontology/foundingDate
|
"1993-11-09"^^xsd:date
|
| http://dbpedia.org/ontology/foundingYear
|
1993
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Investment_company +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chairman +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Schaffhausen +
, http://dbpedia.org/resource/Switzerland +
|
| http://dbpedia.org/ontology/netIncome
|
6.91E8
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Investment_company +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/BB_Biotech.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Aktiengesellschaft +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.bbbiotech.ch +
|
| http://dbpedia.org/ontology/wikiPageID
|
21969441
|
| http://dbpedia.org/ontology/wikiPageLength
|
11794
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1121426103
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Nasdaq +
, http://dbpedia.org/resource/Cardiovascular_diseases +
, http://dbpedia.org/resource/Aktiengesellschaft +
, http://dbpedia.org/resource/Health_technology +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Vertex_Pharmaceuticals +
, http://dbpedia.org/resource/Closed-end_fund +
, http://dbpedia.org/resource/Financial_risk_management +
, http://dbpedia.org/resource/Moderna +
, http://dbpedia.org/resource/Financial_instrument +
, http://dbpedia.org/resource/Borsa_Italiana +
, http://dbpedia.org/resource/Gene_therapy +
, http://dbpedia.org/resource/Inborn_errors_of_metabolism +
, http://dbpedia.org/resource/TecDAX +
, http://dbpedia.org/resource/Investment_company +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_SIX_Swiss_Exchange +
, http://dbpedia.org/resource/Schaffhausen +
, http://dbpedia.org/resource/Agios_Pharmaceuticals +
, http://dbpedia.org/resource/Autoimmune_disease +
, http://dbpedia.org/resource/Alnylam_Pharmaceuticals +
, http://dbpedia.org/resource/Investment_management +
, http://dbpedia.org/resource/RNA_therapeutics +
, http://dbpedia.org/resource/Incyte +
, http://dbpedia.org/resource/Argenx +
, http://dbpedia.org/resource/Fundamental_analysis +
, http://dbpedia.org/resource/Dividend +
, http://dbpedia.org/resource/SIX_Swiss_Exchange +
, http://dbpedia.org/resource/Category:Investment_management_companies_of_Switzerland +
, http://dbpedia.org/resource/Assets_Under_Management +
, http://dbpedia.org/resource/Performance_attribution +
, http://dbpedia.org/resource/Ionis_Pharmaceuticals +
, http://dbpedia.org/resource/Cell_therapy +
, http://dbpedia.org/resource/Long/short_equity +
, http://dbpedia.org/resource/BB_Healthcare_Trust +
, http://dbpedia.org/resource/Total_shareholder_return +
, http://dbpedia.org/resource/Net_asset_value +
, http://dbpedia.org/resource/Category:Investment_companies_of_Switzerland +
, http://dbpedia.org/resource/Income_statement +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Market_capitalization +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Infection +
, http://dbpedia.org/resource/Stock_market_index +
, http://dbpedia.org/resource/Hedge_fund +
, http://dbpedia.org/resource/Neurocrine_Biosciences +
, http://dbpedia.org/resource/Switzerland +
|
| http://dbpedia.org/property/assets
|
4.357E9
|
| http://dbpedia.org/property/foundation
|
"1993-11-09"^^xsd:date
|
| http://dbpedia.org/property/homepage
|
http://www.bbbiotech.ch +
|
| http://dbpedia.org/property/industry
|
Investments
|
| http://dbpedia.org/property/keyPeople
|
Erich Hunziker
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Schaffhausen +
, http://dbpedia.org/resource/Switzerland +
|
| http://dbpedia.org/property/logo
|
BB Biotech.svg
|
| http://dbpedia.org/property/logoSize
|
235
|
| http://dbpedia.org/property/name
|
BB Biotech AG
|
| http://dbpedia.org/property/netIncome
|
6.91E8
|
| http://dbpedia.org/property/products
|
Investment in biotechnology companies
|
| http://dbpedia.org/property/tradedAs
|
FWB:BBZAEuronext:BIO.MI
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Aktiengesellschaft +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Start_date +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Profit +
, http://dbpedia.org/resource/Template:SWX +
, http://dbpedia.org/resource/Template:Br +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Switzerland-company-stub +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_listed_on_the_SIX_Swiss_Exchange +
, http://dbpedia.org/resource/Category:Investment_companies_of_Switzerland +
, http://dbpedia.org/resource/Category:Investment_management_companies_of_Switzerland +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/135787447 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/BB_Biotech?oldid=1121426103&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/BB_Biotech.svg +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.bbbiotech.ch +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/BB_Biotech +
|
| http://xmlns.com/foaf/0.1/name
|
BB Biotech AG
|
| owl:sameAs |
http://fr.dbpedia.org/resource/BB_Biotech +
, http://it.dbpedia.org/resource/BB_Biotech +
, http://viaf.org/viaf/135787447 +
, http://yago-knowledge.org/resource/BB_Biotech +
, http://dbpedia.org/resource/BB_Biotech +
, http://fa.dbpedia.org/resource/%D8%A8%DB%8C%E2%80%8C%D8%A8%DB%8C_%D8%A8%D8%A7%DB%8C%D9%88%D8%AA%DA%A9 +
, http://de.dbpedia.org/resource/BB_Biotech +
, http://d-nb.info/gnd/10014374-X +
, https://global.dbpedia.org/id/4qbY4 +
, http://rdf.freebase.com/ns/m.05p1vv8 +
, http://www.wikidata.org/entity/Q654950 +
|
| rdf:type |
http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/NondepositoryFinancialInstitution108419984 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompanies +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/WikicatInformationTechnologyCompaniesOfSwitzerland +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnTheFrankfurtStockExchange +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatInvestmentCompaniesOfSwitzerland +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1993 +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnTheBorsaItaliana +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/FinancialInstitution108054721 +
, http://dbpedia.org/class/yago/InvestmentCompany108070850 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
|
| rdfs:comment |
BB Biotech AG is a Swiss investment compan … BB Biotech AG is a Swiss investment company in the field of biotechnology. Since 1993 it is listed on the SIX Swiss Exchange, since 1997 on the German TecDAX and since 2000 on the Italian Borsa Italiana. The company invests mainly in the United States and Western Europe. BB Biotech is managed by Bellevue Asset Management, a division of Bellevue Group and accounts for approximately 40% of the Group's Assets Under Management.0% of the Group's Assets Under Management.
, BB Biotech è una delle più grandi società di investimento nel campo delle biotecnologie del mondo. La società è quotata sul listino di Borsa Italiana dove è presente nell'indice FTSE Italia STAR.
, Die BB Biotech AG ist eine Schweizer Biotechnologie-Investmentgesellschaft.
, BB Biotech (SIX : BIO) est une entreprise suisse qui faisait partie de l'indice TecDAX. BB Biotech est une société de portefeuille spécialisée dans la prise de participations dans des sociétés de biotechnologies.
|
| rdfs:label |
BB Biotech
|
